캐나다 - 영어 - Health Canada

apotex inc - abacavir (abacavir sulfate); lamivudine; zidovudine - tablet - 300mg; 150mg; 300mg - abacavir (abacavir sulfate) 300mg; lamivudine 150mg; zidovudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

캐나다 - 영어 - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 50mg - ivacaftor 50mg - cystic fibrosis transmembrane conductance regulator potentiators

캐나다 - 영어 - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 75mg - ivacaftor 75mg - cystic fibrosis transmembrane conductance regulator potentiators

캐나다 - 영어 - Health Canada

aurobindo pharma limited (unit iii) - lamivudine - solution - 10mg - lamivudine 10mg - nucleoside and nucleotide reverse transcriptase inhibitors

미국 - 영어 - NLM (National Library of Medicine)

jacobus pharmaceutical company,inc - amifampridine (unii: ru4s6e2g0j) (amifampridine - unii:ru4s6e2g0j) - ruzurgi is indicated for the treatment of lambert-eaton myasthenic syndrome (lems) in patients 6 to less than 17 years of age. ruzurgi is contraindicated in patients with: - a history of seizures [see warnings and precautions (5.1)] - hypersensitivity to amifampridine or another aminopyridine [see warnings and precautions (5.2)] risk summary there are no data on the developmental risk associated with the use of ruzurgi in pregnant women. animal studies to assess the potential adverse effects of amifampridine on embryofetal development have not been conducted. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. risk summary there are no data on the presence of amifampridine or the 3-n-acetyl-amifampridine metabolite in human milk, the effects on the breastfed infant, or the effects on mi

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aussiesupps pty ltd - natural fish oil, quantity: 1000 mg (equivalent: docosahexaenoic acid, qty 120 mg; equivalent: eicosapentaenoic acid, qty 180 mg) - capsule, soft - excipient ingredients: soya oil; purified water; d-alpha-tocopherol; gelatin; glycerol - maintain/support eye health ; maintain/support general health and wellbeing ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis (linked indication:decrease/reduce/relieve mild joint aches and pains; decrease/reduce/relieve mild joint inflammation/swelling); maintain/support heart health ; maintain/support brain health

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 59.1 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: titanium dioxide; croscarmellose sodium; povidone; sodium stearylfumarate; gelatin; pregelatinised maize starch; iron oxide black; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 39.4 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: gelatin; pregelatinised maize starch; titanium dioxide; iron oxide red; povidone; sodium stearylfumarate; iron oxide yellow; croscarmellose sodium; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - oseltamivir phosphate, quantity: 98.5 mg (equivalent: oseltamivir, qty mg) - capsule, hard - excipient ingredients: iron oxide red; croscarmellose sodium; purified talc; iron oxide black; gelatin; titanium dioxide; pregelatinised maize starch; iron oxide yellow; sodium stearylfumarate; povidone; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - talminex is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,talminex is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aussiesupps pty ltd - ascorbic acid, quantity: 250 mg; zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); echinacea purpurea, quantity: 125 mg (equivalent: echinacea purpurea, qty 750 mg); colecalciferol, quantity: 0.0025 mg - tablet, film coated - excipient ingredients: hypromellose; microcrystalline cellulose; magnesium stearate; silicon dioxide; crospovidone; croscarmellose sodium; povidone; calcium hydrogen phosphate dihydrate; titanium dioxide; chlorophyllin-copper complex; macrogol 400; carnauba wax; maize starch; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support immune system health ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve symptoms of common cold ; maintain/support wound healing